245 related articles for article (PubMed ID: 18065498)
1. COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker.
Hesselstrand R; Kassner A; Heinegård D; Saxne T
Ann Rheum Dis; 2008 Sep; 67(9):1242-8. PubMed ID: 18065498
[TBL] [Abstract][Full Text] [Related]
2. Cartilage Oligomeric Matrix Protein (COMP) in systemic sclerosis (SSc): role in disease severity and subclinical rheumatoid arthritis overlap.
Gheita TA; Hussein H
Joint Bone Spine; 2012 Jan; 79(1):51-6. PubMed ID: 21497537
[TBL] [Abstract][Full Text] [Related]
3. Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease.
Hesselstrand R; Andréasson K; Wuttge DM; Bozovic G; Scheja A; Saxne T
Rheumatology (Oxford); 2012 May; 51(5):915-20. PubMed ID: 22253028
[TBL] [Abstract][Full Text] [Related]
4. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.
Farina G; Lemaire R; Pancari P; Bayle J; Widom RL; Lafyatis R
Ann Rheum Dis; 2009 Mar; 68(3):435-41. PubMed ID: 18408251
[TBL] [Abstract][Full Text] [Related]
5. Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts.
Farina G; Lemaire R; Korn JH; Widom RL
Matrix Biol; 2006 May; 25(4):213-22. PubMed ID: 16520029
[TBL] [Abstract][Full Text] [Related]
6. A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis.
Farina G; Lafyatis D; Lemaire R; Lafyatis R
Arthritis Rheum; 2010 Feb; 62(2):580-8. PubMed ID: 20112379
[TBL] [Abstract][Full Text] [Related]
7. High frequency ultrasound of skin involvement in systemic sclerosis - a follow-up study.
Hesselstrand R; Carlestam J; Wildt M; Sandqvist G; Andréasson K
Arthritis Res Ther; 2015 Nov; 17():329. PubMed ID: 26584645
[TBL] [Abstract][Full Text] [Related]
8. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
[TBL] [Abstract][Full Text] [Related]
9. Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.
Dodge GR; Hawkins D; Boesler E; Sakai L; Jimenez SA
Osteoarthritis Cartilage; 1998 Nov; 6(6):435-40. PubMed ID: 10343777
[TBL] [Abstract][Full Text] [Related]
10. High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference.
Li H; Furst DE; Jin H; Sun C; Wang X; Yang L; He J; Wang Y; Liu A
Arthritis Res Ther; 2018 Aug; 20(1):181. PubMed ID: 30115105
[TBL] [Abstract][Full Text] [Related]
11. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
Wisłowska M; Jabłońska B
Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
[TBL] [Abstract][Full Text] [Related]
12. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
[TBL] [Abstract][Full Text] [Related]
13. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.
Clark AG; Jordan JM; Vilim V; Renner JB; Dragomir AD; Luta G; Kraus VB
Arthritis Rheum; 1999 Nov; 42(11):2356-64. PubMed ID: 10555031
[TBL] [Abstract][Full Text] [Related]
14. A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 years.
Erhart-Hledik JC; Favre J; Asay JL; Smith RL; Giori NJ; Mündermann A; Andriacchi TP
Osteoarthritis Cartilage; 2012 Nov; 20(11):1309-15. PubMed ID: 22868052
[TBL] [Abstract][Full Text] [Related]
15. High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.
Correia C; Mawe S; Lofgren S; Marangoni RG; Lee J; Saber R; Aren K; Cheng M; Teaw S; Hoffmann A; Goldberg I; Cowper SE; Khatri P; Hinchcliff M; Mahoney JM
Arthritis Res Ther; 2020 Mar; 22(1):48. PubMed ID: 32171325
[TBL] [Abstract][Full Text] [Related]
16. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
Nakajima S; Naruto T; Miyamae T; Imagawa T; Mori M; Nishimaki S; Yokota S
Mod Rheumatol; 2009; 19(1):42-6. PubMed ID: 18726067
[TBL] [Abstract][Full Text] [Related]
17. The heritable determinants of cartilage oligomeric matrix protein.
Williams FM; Andrew T; Saxne T; Heinegard D; Spector TD; MacGregor AJ
Arthritis Rheum; 2006 Jul; 54(7):2147-51. PubMed ID: 16802351
[TBL] [Abstract][Full Text] [Related]
18. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
Skoumal M; Kolarz G; Klingler A
Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
[TBL] [Abstract][Full Text] [Related]
20. Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis.
Otteby KE; Holmquist E; Saxne T; Heinegård D; Hesselstrand R; Blom AM
Arthritis Res Ther; 2013; 15(6):R215. PubMed ID: 24330664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
